265 related articles for article (PubMed ID: 35390478)
21. COVID-19 vaccine and autoimmune hepatitis.
Sookaromdee P; Wiwanitkit V
Rev Esp Enferm Dig; 2022 Oct; 114(10):631. PubMed ID: 35469403
[TBL] [Abstract][Full Text] [Related]
22. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Cerebral Venous Thrombosis Following SARS-CoV-2 Infection vs mRNA SARS-CoV-2 Vaccination in Singapore.
Tu TM; Yi SJ; Koh JS; Saffari SE; Hoe RHM; Chen GJ; Chiew HJ; Tham CH; Seet CYH; Yong MH; Yong KP; Hui AC; Fan BE; Tan BY; Quek AML; Seet RCS; Yeo LLL; Tan K; Thirugnanam UN
JAMA Netw Open; 2022 Mar; 5(3):e222940. PubMed ID: 35297971
[TBL] [Abstract][Full Text] [Related]
24. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
[TBL] [Abstract][Full Text] [Related]
25. Insights into new-onset autoimmune diseases after COVID-19 vaccination.
Guo M; Liu X; Chen X; Li Q
Autoimmun Rev; 2023 Jul; 22(7):103340. PubMed ID: 37075917
[TBL] [Abstract][Full Text] [Related]
26. Autoimmune hepatitis following COVID-19 vaccination: True causality or mere association?
Tan CK; Wong YJ; Wang LM; Ang TL; Kumar R
J Hepatol; 2021 Nov; 75(5):1250-1252. PubMed ID: 34153398
[No Abstract] [Full Text] [Related]
27. Severe Hepatitis-associated Aplastic Anemia Following COVID-19 mRNA Vaccination.
Yamamoto M; Keino D; Sumii S; Yokosuka T; Goto H; Inui A; Sogo T; Kawakami M; Tanaka M; Yanagimachi M
Intern Med; 2023 Jun; 62(12):1813-1816. PubMed ID: 36948624
[TBL] [Abstract][Full Text] [Related]
28. Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
Abi Zeid Daou C; Natout MA; El Hadi N
J Med Virol; 2021 Oct; 93(10):6027-6029. PubMed ID: 34050949
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune hepatitis with history of HCV treatment triggered by COVID-19 vaccination: case report and literature review.
Hasegawa N; Matsuoka R; Ishikawa N; Endo M; Terasaki M; Seo E; Tsuchiya K
Clin J Gastroenterol; 2022 Aug; 15(4):791-795. PubMed ID: 35716255
[TBL] [Abstract][Full Text] [Related]
30. Immediate reactions after mRNA SARS-CoV-2 vaccination.
Jeimy S; Wong T; Song C
CMAJ; 2021 Dec; 193(48):E1842. PubMed ID: 34772737
[No Abstract] [Full Text] [Related]
31. Autoimmune hepatitis after SARS-C¬¬oV-2 vaccination.
Díez Ruiz S; Quiñones Castro R; Alcoba Vega L; Martín Izquierdo A; González Puente I; Rodríguez Martín L; Díez Rodríguez R; Jorquera Plaza F
Rev Esp Enferm Dig; 2023 Jul; 115(7):406. PubMed ID: 37114399
[TBL] [Abstract][Full Text] [Related]
32. Thyroid as a target of adjuvant autoimmunity/inflammatory syndrome due to mRNA-based SARS-CoV2 vaccination: from Graves' disease to silent thyroiditis.
Pujol A; Gómez LA; Gallegos C; Nicolau J; Sanchís P; González-Freire M; López-González ÁA; Dotres K; Masmiquel L
J Endocrinol Invest; 2022 Apr; 45(4):875-882. PubMed ID: 34792795
[TBL] [Abstract][Full Text] [Related]
33. New-onset autoimmune hepatitis following mRNA COVID-19 vaccination in a 36-year-old woman with primary sclerosing cholangitis - should we be more vigilant?
Zhou T; Fronhoffs F; Dold L; Strassburg CP; Weismüller TJ
J Hepatol; 2022 Jan; 76(1):218-220. PubMed ID: 34450237
[No Abstract] [Full Text] [Related]
34. [Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].
Matsumura A; Katsuki K; Akimoto M; Sakuma T; Nakajima Y; Miyazaki T; Fujisawa S; Nakajima H
Rinsho Ketsueki; 2021; 62(11):1639-1642. PubMed ID: 34866090
[TBL] [Abstract][Full Text] [Related]
35. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological Characteristics of Autoimmune-Like Hepatitis Induced by COVID-19 mRNA Vaccine (Pfizer-BioNTech, BNT162b2): A Case Report and Literature Review.
Kim JH; Chae HB; Woo S; Song MS; Kim HJ; Woo CG
Int J Surg Pathol; 2023 Sep; 31(6):1156-1162. PubMed ID: 37272061
[TBL] [Abstract][Full Text] [Related]
37. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
[TBL] [Abstract][Full Text] [Related]
38. Autoimmune and inflammatory thyroid diseases following vaccination with SARS-CoV-2 vaccines: from etiopathogenesis to clinical management.
Caron P
Endocrine; 2022 Dec; 78(3):406-417. PubMed ID: 35763241
[TBL] [Abstract][Full Text] [Related]
39. Autoimmune phenomena following SARS-CoV-2 vaccination.
Ishay Y; Kenig A; Tsemach-Toren T; Amer R; Rubin L; Hershkovitz Y; Kharouf F
Int Immunopharmacol; 2021 Oct; 99():107970. PubMed ID: 34280851
[TBL] [Abstract][Full Text] [Related]
40. Probable autoimmune hepatitis reactivated after COVID-19 vaccination.
Torrente S; Castiella A; Garmendia M; Zapata E
Gastroenterol Hepatol; 2022 Apr; 45 Suppl 1():115-116. PubMed ID: 34756976
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
